British Pharmacopoeia 2021
Helping you to do your job quickly, easily and with confidence
New, legally enforced standards, available from 1 August 2020. All European Pharmacopoeia texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2021
The BP 2021 supersedes the BP 2021 and becomes legally effective on 1 January 2021. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
- 30 new BP monographs, 20 new Ph. Eur. monographs.
- 171 amended BP monographs.
- All monographs from the Ph. Eur. 10th edition and supplements 10.1 and 10.2 are included.
- Ph. Eur. supplements 10.3, 10.4, and 10.5 included as in-year online and download product updates.
- New Tracked Changes functionality makes it easier to identify changes made to monographs and view the most recent versions suitable to you. Save time when reading through monographs with clear symbols highlighting different types of changes and customise your view by toggling through different levels of detail.
- Streamlined Timeline functionality and cleaner design helps you find the information you need. Easily see the editions of the BP in which a monograph was published and subsequently revised. Archive subscribers can now access all previous editions of BP and Ph. Eur., through the improved navigation.
- Concise 'How to use the BP' guide, helping you to comply with the BP, navigate more effectively and follow formulated product monographs.
- We're releasing 8 new BPCRS to coincide with the new and revised monographs in the BP 2021. This means you can order the new chemical reference standards alongside the BP 2021 - helping you comply with the new standards from January 2021. Browse the BPCRS catalogue.
Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats - including full online and offline access.
Key customer groups
If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life. This makes the BP relevant and essential for:
- Global suppliers and sellers of active pharmaceutical ingredients and medicinal products including but not limited to; Pharmaceutical researchers and manufacturers, chemists, biotechnologists, quality assurance and quality controls inspectors, laboratory technicians and regulatory bodies.
- Specialist researchers and lecturers in the field of pharmacy, biological science, biochemistry and pharmaceutical science can use the BP for research into medicinal products using the most up-to-date monographs.
British Pharmacopoeia 2021
Single-user licences and packages
Visit the BP website to purchase and view single-user licence package options.
*Single-user licences are granted solely to one designated holder.
If online access for more than one online user is required, organisations can enjoy cost-effective simultaneous access to the full text of the BP 2021 edition, on workstations, laptops and other portable devices.
For multi-user licences, call or email our dedicated team:
- +44(0) 1603 985982
Online customers can select from additional add-on options such as:
- BP Archive - to get access to all BP editions from 2014 to date
- British Approved Names (BAN) 2017 & Supplement No.4 - giving access to this reference source of medicinal substance names